These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 22448244)

  • 1. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis.
    Noto H; Goto A; Tsujimoto T; Noda M
    PLoS One; 2012; 7(3):e33411. PubMed ID: 22448244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monotherapy with Metformin versus Sulfonylureas and Risk of Cancer in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis.
    Mekuria AN; Ayele Y; Tola A; Mishore KM
    J Diabetes Res; 2019; 2019():7676909. PubMed ID: 31828167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.
    Decensi A; Puntoni M; Goodwin P; Cazzaniga M; Gennari A; Bonanni B; Gandini S
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1451-61. PubMed ID: 20947488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis.
    Yao L; Liu M; Huang Y; Wu K; Huang X; Zhao Y; He W; Zhang R
    Dis Markers; 2019; 2019():6230162. PubMed ID: 30881522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and breast cancer risk: a meta-analysis and critical literature review.
    Col NF; Ochs L; Springmann V; Aragaki AK; Chlebowski RT
    Breast Cancer Res Treat; 2012 Oct; 135(3):639-46. PubMed ID: 22847511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.
    Gandini S; Puntoni M; Heckman-Stoddard BM; Dunn BK; Ford L; DeCensi A; Szabo E
    Cancer Prev Res (Phila); 2014 Sep; 7(9):867-85. PubMed ID: 24985407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
    Meng F; Song L; Wang W
    J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
    [No Abstract]   [Full Text] [Related]  

  • 8. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
    Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
    Nie Z; Zhu H; Gu M
    Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon neoplasia in patients with type 2 diabetes on metformin: A meta-analysis.
    Rokkas T; Portincasa P
    Eur J Intern Med; 2016 Sep; 33():60-6. PubMed ID: 27318643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.
    Ma SJ; Zheng YX; Zhou PC; Xiao YN; Tan HZ
    Oncotarget; 2016 Oct; 7(40):66202-66211. PubMed ID: 27494848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis.
    Tang YL; Zhu LY; Li Y; Yu J; Wang J; Zeng XX; Hu KX; Liu JY; Xu JX
    Biomed Res Int; 2017; 2017():5905384. PubMed ID: 28409158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
    Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS
    Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis.
    Zhang ZJ; Bi Y; Li S; Zhang Q; Zhao G; Guo Y; Song Q
    Am J Epidemiol; 2014 Jul; 180(1):11-4. PubMed ID: 24920786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis.
    Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):627-635. PubMed ID: 29618465
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis.
    Deng D; Yang Y; Tang X; Skrip L; Qiu J; Wang Y; Zhang F
    Diabetes Metab Res Rev; 2015 Sep; 31(6):595-602. PubMed ID: 25708557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
    Hu J; Chen JB; Cui Y; Zhu YW; Ren WB; Zhou X; Liu LF; Chen HQ; Zu XB
    Medicine (Baltimore); 2018 Jul; 97(30):e11596. PubMed ID: 30045293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis.
    Cheng Y; Chen Y; Zhou C; Shen L; Tu F; Xu J; Liu C
    Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):73-81. PubMed ID: 31300371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis.
    Zhang ZJ; Zheng ZJ; Kan H; Song Y; Cui W; Zhao G; Kip KE
    Diabetes Care; 2011 Oct; 34(10):2323-8. PubMed ID: 21949223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.
    Stevens RJ; Ali R; Bankhead CR; Bethel MA; Cairns BJ; Camisasca RP; Crowe FL; Farmer AJ; Harrison S; Hirst JA; Home P; Kahn SE; McLellan JH; Perera R; Plüddemann A; Ramachandran A; Roberts NW; Rose PW; Schweizer A; Viberti G; Holman RR
    Diabetologia; 2012 Oct; 55(10):2593-2603. PubMed ID: 22875195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.